McKesson Corporation

MCK · Healthcare

$938.84
+0.92% today

What a holder would want to know before buying MCK: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $725.17 · May 2026High $995.69 · Mar 2026

Today’s price is 29% above the lowest point of the past year and 6% below the highest.

Over the past year it was cheaper than today on 92% of days and more expensive on 8%. Over the last 10 years: cheaper on 99% of days.

10% above its average price of the last 200 trading days.

How bad does it get

Fell 20% or more twice in 10 years. The deepest fall was 45%; the longest took 4.8 years to get back to its peak. Every one recovered.

Now 6% below the Mar 2026 peak.

Aug 2024
−24%back in 7 months
Jul 2016
−45%back in 4.8 years
What you own

McKesson Corporation · Healthcare · Medical Distribution · a large company worth $109.46B

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions,…

Is it making money?
2023
2024
2025
2026

revenue profit

Sales of $403.43B in 2026, with $4.76B of profit. Sales grew in 3 of the last 3 years.

Keeps about 1 cents of every dollar of sales as profit.

Is it healthy?
Cash
$5.16B
Debt
$11.80B
Free cash flow / yr
$6.80B

Would need about 1.7 years of free cash flow to repay all its debt.

Is it expensive?

You pay $25 for every $1 of last year’s profit, and $19 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays 0.40% a year in dividends at today’s price · next ex-dividend Sep 1.

What others are doing

15 analysts: 12 say buy, 3 hold, 0 sell. Their average 12-month target is $980.67 (range $845.00–$1,070.00).

Insiders made 0 purchases and 10 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy MCK with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.